MDx-Chex for BC-GP and BC-GN are controls designed to evaluate the entire analytical process of the Luminex VERIGENE® BC-GP and BC-GN Panels for sepsis. With MDx-Chex for BC-GP and BC-GN, you can track lot-to-lot performance of the BC-GP and BC-GN assays and reduce the occurrence of incorrect results due to instrument or assay failures.

• Patient-like matrix of inactivated microorganisms, blood cells and culture media components
• Can be directly used on the Luminex VERIGENE system
• Complete coverage of all BC-GP or BC-GN Panel targets in a single vial
• Negative controls contain only blood cells and culture media components for a true patient-like negative control
• Challenges and verifies the entire analytical process of the Luminex VERIGENE assays
• Reduces preanalytical variables such as pipetting errors and cross-contamination
• Easy to use - simply pipette like a patient sample

MDx-Chex for BC-GP and BC-GN are patient-like full process controls designed to validate the entire analytical process of the Luminex VERIGENE BC-GP and BC-GN Panels, including automated nucleic acid extraction, DNA purification, hybridization of target DNA to the microarray, hybridization of gold nanoparticles to target DNA and silver staining of hybridized probes.

MDx-Chex for BC-GP and BC-GN cover all targets tested with Luminex VERIGENE for BC-GP or BC-GN, respectively. Microorganisms are intact, inactivated and suspended in a matrix of stabilized red blood cells, white blood cells and blood culture media components, providing you with a control that can be mixed and pipetted like a positive patient sample, reducing the risk of cross-contamination, pipetting errors or other pre-analytical variables that may cause incorrect results.